KM Biologics commences clinical trial of COVID-19 vaccine candidate
The study is a combined Phase 1 and Phase 2 trial involving 210 subjects to test the vaccine’s safety and ability to trigger an…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Interval between two doses of COVISHIELD increased to 4-8 weeks
Protection enhanced if the second dose of COVISHIELD is administered between 6-8 weeks, says NTAGI and NEGVAC
RDIF, Virchow Biotech sign agreement to produce 200 million doses of Sputnik V vaccine
The technology transfer is expected to be completed in the second quarter of 2021 followed by full-scale commercial production of…
New data boosts AstraZeneca COVID-19 vaccine in US
The trials in the US, Chile and Peru showed the vaccine was 79 per cent effective at preventing symptomatic COVID-19
Researchers at IISER Bhopal, Nebraska University identify drug that can be repurposed to treat…
Rapamycin used to prevent organ rejection after transplants and in cancer treatment was found to have anti-ageing effect and…
South Africa sells COVID-19 vaccines procured from AstraZeneca to other AU member states
The country had paused AstraZeneca vaccinations last month because of a small trial showing the shot offered minimal protection…
8-10 months protection possible with COVID-19 vaccine: AIIMS director
He said the biggest reason for the surge in cases is that people feel the pandemic is over and they are not following…
Premas Biotech, Oramed announce single-dose oral COVID-19 vaccine candidate
Clinical trials expected to commence Q2 2021
RDIF, Stelis Biopharma join hands for 200 mn doses of Sputnik V vaccine
The parties intend to commence supplies from the Q3 of 2021
AstraZeneca to supply 500,000 additional doses of COVID-19 antibody cocktail to US
The drugmaker said the $205 million US extension for 500,000 antibody doses builds on a contract agreed with government agencies…
EU warns about tougher export control of COVID vaccines as internal feuds intensify
Germany, Italy, France and Denmark were among those supporting tougher export controls
J&J developing many next-gen vaccines against COVID-19: CEO
It had previously said it was developing a second-generation vaccine that would target the variant first identified in South…
India asks States to manage immunisation drives better
Urges them to avoid wastage of 'elixir-like' COVID-19 vaccines
Maha wants to manufacture Covaxin at Haffkine: Rajesh Tope
The state government is also ready if Bharat Biotech wants to produce Covaxin in Haffkine Institute, says Tope
SII gets purchase order from government for 10 crore doses of Covishield
The cost of the 10-crore doses would be borne by the health ministry
Moderna commences trial of COVID-19 vaccine in children
The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart in children aged six months to…
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses
Gland Pharma said it would explore more deals for the vaccine
Ocugen intends to sell 100 million doses of COVAXIN in US in 2021
Cracking the US market would be a significant milestone for the company and India’s vaccine industry
No evidence of greater blood clot risk from vaccine: AstraZeneca
Its review covered more than 17 million people vaccinated in the UK and EU and comes after health authorities in some countries…
Researchers reveal novel coronavirus jumped from bats to humans with ”very little…
However, some changes such as the D614G mutation, and similar tweaks in the virus spike protein has affected its biology